The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pre-MEASURE: Multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in first remission.
 
Chris S. Hourigan
Research Funding - Sellas Life Sciences (Inst)
Other Relationship - Archer Diagnostics; Mission Bio; Qiagen; TwinStrand Biosciences
 
Laura Williams Dillon
No Relationships to Disclose
 
Gege Gui
No Relationships to Disclose
 
Niveditha Ravindra
No Relationships to Disclose
 
Zoë Wong
No Relationships to Disclose
 
Georgia Andrew
No Relationships to Disclose
 
Devdeep Mukherjee
No Relationships to Disclose
 
Firas El Chaer
No Relationships to Disclose
 
Chris Yoon
No Relationships to Disclose
 
Stephen Spellman
No Relationships to Disclose
 
Alan Howard
No Relationships to Disclose
 
Jeffery Auletta
Consulting or Advisory Role - Ascella Health; Cardinal Health
 
Steven Michael Devine
Consulting or Advisory Role - Bristol-Myers Squibb; Sanofi
 
Antonio Martin Jimenez Jimenez
Research Funding - Abbvie
 
Marcos J.G. De Lima
Consulting or Advisory Role - Celgene; Pfizer
Research Funding - Celgene; Pfizer
 
Mark Robert Litzow
Consulting or Advisory Role - Jazz Pharmaceuticals; Omeros
Research Funding - Abbvie; Abbvie/Genentech; Actinium Pharmaceuticals; Amgen; Astellas Pharma; Pluristem Therapeutics; Tolero Pharmaceuticals
Other Relationship - Biosight
 
Partow Kebriaei
Honoraria - Kite, a Gilead company; Novartis; Pfizer
Consulting or Advisory Role - Jazz Pharmaceuticals
Research Funding - Amgen; ZIOPHARM Oncology
Travel, Accommodations, Expenses - Kite, a Gilead company; Novartis; Pfizer
 
Wael Saber
No Relationships to Disclose
 
Daniel Jordan Weisdorf
Consulting or Advisory Role - Fate Therapeutics; Incyte
Research Funding - Incyte
 
Kristin Page
No Relationships to Disclose